DalsnaFinance › IPOs › Regencell Bioscience Holdings › IPO

Regencell Bioscience Holdings Ltd IPO

Completed

Regencell Bioscience Holdings Ltd completed its initial public offering on NASDAQ on July 16, 2021, pricing at $9.50 a share.

Ticker	RGC
Exchange	NASDAQ
Status	Completed
Listing date	July 16, 2021
Offering price	$9.50
Shares offered	2,300,000
Total raised	$22M

The offering

Regencell Bioscience Holdings Ltd sold 2,300,000 shares at $9.50 each on NASDAQ. Multiplied out, that is $21.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $22 million total recorded for the deal.

Company coverage

Regencell Bioscience Holdings Ltd — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for Regencell Bioscience Holdings Ltd. This page is general information, not investment advice.